Journal article icon

Journal article

Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

Abstract:
Preclinical models propose that the onset of psychosis is associated with hippocampal hyperactivity, thought to be driven by cortical GABAergic interneuron dysfunction and disinhibition of pyramidal neurons. Recent neuroimaging studies suggest that resting hippocampal perfusion is increased in subjects at ultra-high risk (UHR) for psychosis, but how this may be related to GABA concentrations is unknown. The present study used a multimodal neuroimaging approach to address this issue in UHR subjects. Proton magnetic resonance spectroscopy and pulsed-continuous arterial spin labeling imaging were acquired to investigate the relationship between medial prefrontal (MPFC) GABA+ levels (including some contribution from macromolecules) and hippocampal regional cerebral blood flow (rCBF) in 36 individuals at UHR of psychosis, based on preclinical evidence that MPFC dysfunction is involved in hippocampal hyperactivity. The subjects were then clinically monitored for 2 years: during this period, 7 developed a psychotic disorder and 29 did not. At baseline, MPFC GABA+ levels were positively correlated with rCBF in the left hippocampus (region of interest analysis, p = .044 family-wise error corrected, FWE). This correlation in the left hippocampus was significantly different in UHR subjects who went on to develop psychosis relative to those who did not (p = .022 FWE), suggesting the absence of a correlation in the latter subgroup. These findings provide the first human evidence that MPFC GABA+ concentrations are related to resting hippocampal perfusion in the UHR state, and offer some support for a link between GABA levels and hippocampal function in the development of psychosis
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41386-017-0004-6

Authors

More by this author
Role:
Author
ORCID:
0000-0002-7870-066X
More by this author
Role:
Author
ORCID:
0000-0002-4131-2970
More by this author
Role:
Author
ORCID:
0000-0001-8164-0357
More by this author
Role:
Author
ORCID:
0000-0001-7880-2300


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
Neuropsychopharmacology More from this journal
Volume:
43
Issue:
13
Pages:
2652-2659
Publication date:
2018-01-30
DOI:
EISSN:
1740-634X
ISSN:
0893-133X


Language:
English
Keywords:
Pubs id:
827249
Local pid:
pubs:827249
Source identifiers:
W2781503439
Deposit date:
2026-01-16
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP